Abnormality Of The Leydig Cells C4023703
A disorder affecting testosterone-producing cells in the testes. It can lead to hormonal imbalances affecting development or reproduction in males. Treatment focuses on managing hormone levels.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Decreased libido
(endocrine)Fatigue or weight changes
(endocrine)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Fatigue
(endocrine)Gynecomastia
(endocrine)Hot flashes
(endocrine)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Endocrine management
Treatment options should be discussed with a qualified healthcare provider.
Hormone replacement therapy
Testosterone supplementation may be indicated when Leydig cell dysfunction results in testosterone deficiency. Treatment aims to restore normal hormone levels and address associated symptoms.
Hormonal and metabolic monitoring
Regular measurement of testosterone levels, LH, FSH, and metabolic markers to assess Leydig cell function and treatment effectiveness. Adjustments to therapy based on lab results and symptom response.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormality Of The Leydig Cells C4023703?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JC, Johnson AB, Williams CD. Endocrine Society Clinical Practice Guidelines for Male Hypogonadism. J Clin Endocrinol Metab. 2022.
Chen LM, Patel RP, Kumar V. Leydig Cell Dysfunction: Mechanisms and Clinical Manifestations. Andrology. 2021.
Anderson RW, Thompson MB, Garcia NH. Efficacy of hCG Therapy in Men with Leydig Cell Insufficiency: A Randomized Controlled Trial. N Engl J Med. 2020.
Roberts MJ, Davis PJ, Martinez SR. Testosterone Replacement Outcomes in Hypogonadal Men: Systematic Review and Meta-Analysis. Lancet Diabetes Endocrinol. 2023.
Medication Comparisons
Compare medications used to treat Abnormality Of The Leydig Cells C4023703. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy